Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)

Abstract Background Beta-blockers are commonly prescribed for patients with cardiovascular disease. Providers have been wary of treating chronic obstructive pulmonary disease (COPD) patients with beta-blockers due to concern for bronchospasm, but retrospective studies have shown that cardio-selectiv...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Sean Duffy, Robert Marron, Helen Voelker, Richard Albert, John Connett, William Bailey, Richard Casaburi, J. Allen Cooper, Jeffrey L. Curtis, Mark Dransfield, MeiLan K. Han, Barry Make, Nathaniel Marchetti, Fernando Martinez, Stephen Lazarus, Dennis Niewoehner, Paul D. Scanlon, Frank Sciurba, Steven Scharf, Robert M. Reed, George Washko, Prescott Woodruff, Charlene McEvoy, Shawn Aaron, Don Sin, Gerard J. Criner, the NIH COPD Clinical Research Network and the Canadian Institutes of Health Research
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2017-06-01
Saila:	Respiratory Research
Gaiak:	COPD Exacerbation Beta-blocker
Sarrera elektronikoa:	http://link.springer.com/article/10.1186/s12931-017-0609-7
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!